Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
30/5 18:48
Key PointsFCPM III sold 818,460 shares of Dyne Therapeutics last quarter; the estimated transaction value was $14.11 million based on average prices....
|
|
|
30/5 18:48
Key PointsFCPM III sold 818,460 shares of Dyne Therapeutics last quarter; the estimated transaction value was $14.11 million based on average prices....